// App-Quantinova.ai

4827 : Co-administration of nicotinic acid (NA) enhances the therapeutic index of KPT-9274 in cancer cells

Researchers

Presenter

  • William Senapedis

Principal Investigators

  • Christian Argueta

  • Yosef Landesman

  • Margaret Lee

  • Sharon Shacham

  • Erkan Balolgu

Medical Centers

  • Karyopharm Therapeutics, Newton, MA

Locations

  • United States

Companies

  • Karyopharm Therapeut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Niacor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved